CASI Pharmaceuticals Stock Performance


USD 2.03  0.06  3.05%   

The firm shows a Beta (market volatility) of 1.4547, which signifies a somewhat significant risk relative to the market. Let's try to break down what CASI Pharmaceuticals's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CASI Pharmaceuticals will likely underperform. Even though it is essential to pay attention to CASI Pharmaceuticals historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. CASI Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate its performance. CASI Pharmaceuticals has an expected return of -1.03%. Please be advised to confirm CASI Pharmaceuticals semi variance, and the relationship between the maximum drawdown and accumulation distribution to decide if CASI Pharmaceuticals performance from the past will be repeated in the future.
CASI Pharmaceuticals Performance
0 of 100
Over the last 90 days CASI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2023. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Structure and Payout Changes

Last Split Factor
Last Split Date

CASI Pharmaceuticals Price Channel

Begin Period Cash Flow57064000.00
Total Cashflows From Investing Activities-20691000.00

CASI Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  400.00  in CASI Pharmaceuticals on September 3, 2022 and sell it today you would lose (203.00)  from holding CASI Pharmaceuticals or give up 50.75% of portfolio value over 90 days. CASI Pharmaceuticals is currently does not generate positive expected returns and assumes 4.5718% risk (volatility on return distribution) over the 90 days horizon. In different words, 39% of stocks are less volatile than CASI Pharmaceuticals, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days CASI Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 3.04 times more volatile than its market benchmark. It trades about -0.22 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.09 per unit of volatility.

CASI Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for CASI Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CASI Pharmaceuticals, and traders can use it to determine the average amount a CASI Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2244

Good Returns
Average Returns
Small Returns
Negative ReturnsCASI
Estimated Market Risk
  actual daily
 39 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average CASI Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CASI Pharmaceuticals by adding it to a well-diversified portfolio.

About CASI Pharmaceuticals Performance

To evaluate CASI Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when CASI Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare CASI Pharmaceuticals Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand CASI Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents CASI Pharmaceuticals's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-469 K-481.3 K
Return on Investment(50.14) (54.10) 
Return on Average Assets(27.56) (29.73) 
Return on Average Equity(44.15) (47.64) 
Return on Invested Capital(0.57) (0.58) 
Return on Sales(1.22) (1.31) 

Things to note about CASI Pharmaceuticals

Checking the ongoing alerts about CASI Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CASI Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

CASI Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

CASI Pharmaceuticals generated a negative expected return over the last 90 days
CASI Pharmaceuticals has high historical volatility and very poor performance
The company reported the previous year's revenue of 30.17 M. Net Loss for the year was (36.65 M) with profit before overhead, payroll, taxes, and interest of 17.61 M.
CASI Pharmaceuticals currently holds about 24.57 M in cash with (26.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
CASI Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 33.0% of the company shares are held by company insiders
Continue to Trending Equities. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for analysis

When running CASI Pharmaceuticals price analysis, check to measure CASI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CASI Pharmaceuticals is operating at the current time. Most of CASI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of CASI Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CASI Pharmaceuticals' price. Additionally, you may evaluate how the addition of CASI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is CASI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CASI Pharmaceuticals. If investors know CASI Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CASI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
27.1 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of CASI Pharmaceuticals is measured differently than its book value, which is the value of CASI Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of CASI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is CASI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CASI Pharmaceuticals' market value can be influenced by many factors that don't directly affect CASI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CASI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine CASI Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CASI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.